Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer atones for Wyeth's misdeeds, again; pays $491m

This article was originally published in Scrip

Executive Summary

While the whistleblowers' share has not been resolved in the $491m settlement involving unlawful marketing of Pfizer's Rapamune (sirolimus), the three people who brought the lawsuits against the company's Wyeth unit under the False Claims Act (FCA) stand to gain up to 25%, with a minimum of 15%, of the $257.4m recovered under the civil liability portion of the case.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC022286

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel